Oprah Winfrey's announcement that she is leaving the board of WeightWatchers sent the company's shares tumbling Thursday -- the latest sign of trouble for the brand as it struggles to compete with new weight-loss drugs.
The departure of Winfrey, who has often addressed her own weight issues during her high profile television and business career, comes after she revealed last year that she was taking prescription anti-obesity medication.
